Integer (NYSE:ITGR) Raised to “Buy” at Wall Street Zen

Integer (NYSE:ITGR) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

Other research analysts also recently issued research reports about the stock. Benchmark reissued a “hold” rating on shares of Integer in a research report on Friday, October 24th. KeyCorp dropped their price target on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Raymond James Financial restated an “outperform” rating and issued a $95.00 target price (down from $143.00) on shares of Integer in a research report on Friday, October 24th. Weiss Ratings reissued a “hold (c-)” rating on shares of Integer in a research note on Friday, October 31st. Finally, Piper Sandler reduced their price objective on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Four research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $96.75.

Integer Stock Performance

Shares of NYSE:ITGR opened at $70.02 on Friday. Integer has a 1-year low of $62.00 and a 1-year high of $146.36. The stock has a market capitalization of $2.45 billion, a P/E ratio of 29.30, a P/E/G ratio of 0.60 and a beta of 0.95. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. The business has a 50-day moving average price of $88.13 and a two-hundred day moving average price of $105.29.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.During the same period in the previous year, the firm posted $1.43 earnings per share. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Equities analysts predict that Integer will post 6.01 earnings per share for the current year.

Integer declared that its board has authorized a stock buyback plan on Tuesday, November 4th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Insider Transactions at Integer

In other Integer news, CEO Payman Khales acquired 3,127 shares of the business’s stock in a transaction dated Thursday, October 30th. The stock was bought at an average price of $64.94 per share, with a total value of $203,067.38. Following the completion of the acquisition, the chief executive officer owned 22,865 shares of the company’s stock, valued at $1,484,853.10. This trade represents a 15.84% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Cheryl C. Capps acquired 1,600 shares of the business’s stock in a transaction dated Thursday, November 6th. The stock was purchased at an average price of $66.70 per share, with a total value of $106,720.00. Following the completion of the acquisition, the director directly owned 11,702 shares in the company, valued at approximately $780,523.40. This represents a 15.84% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 5,843 shares of company stock worth $384,771 over the last 90 days. 2.16% of the stock is owned by insiders.

Institutional Investors Weigh In On Integer

A number of large investors have recently made changes to their positions in the business. Knights of Columbus Asset Advisors LLC lifted its position in Integer by 2.7% during the 1st quarter. Knights of Columbus Asset Advisors LLC now owns 18,685 shares of the medical equipment provider’s stock valued at $2,205,000 after acquiring an additional 489 shares during the period. LPL Financial LLC lifted its holdings in Integer by 11.4% in the first quarter. LPL Financial LLC now owns 49,585 shares of the medical equipment provider’s stock valued at $5,683,000 after acquiring an additional 5,077 shares during the period. First National Advisers LLC bought a new stake in Integer during the first quarter valued at approximately $436,000. XTX Topco Ltd raised its holdings in Integer by 87.1% in the 1st quarter. XTX Topco Ltd now owns 4,190 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 1,951 shares during the period. Finally, Natixis Advisors LLC grew its stake in shares of Integer by 117.7% during the 1st quarter. Natixis Advisors LLC now owns 94,202 shares of the medical equipment provider’s stock valued at $11,117,000 after acquiring an additional 50,924 shares during the period. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.